Terumo Medical Corporation Sustainability Profile
Terumo Medical Corporation, a leading player in the global medical technology industry, is headquartered in the United States. Founded in 1921, the company has established a strong presence in various operational regions, including Europe and Asia, focusing on innovative healthcare solutions. Specialising in products such as blood management systems, vascular intervention devices, and surgical products, Terumo is renowned for its commitment to quality and patient safety. The company’s unique approach combines advanced technology with a deep understanding of clinical needs, setting it apart in a competitive market. With a legacy of innovation and a robust portfolio, Terumo Medical Corporation continues to achieve significant milestones, solidifying its position as a trusted partner in healthcare worldwide.
DitchCarbon Score
How does Terumo Medical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Terumo Medical Corporation's score of 63 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Terumo Medical Corporation, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Terumo Corporation, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or initiatives directly attributed to Terumo Medical Corporation, it is important to note that any climate commitments or targets would likely be inherited from its parent company, Terumo Corporation. This includes potential initiatives related to the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Terumo Corporation. As of now, Terumo Medical Corporation has not publicly outlined specific climate pledges or reduction targets. The absence of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2005 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Terumo Medical Corporation's Industry?
How Carbon Intensive is Terumo Medical Corporation's Location?
Terumo Medical Corporation's Scope 3 Categories Breakdown
Terumo Medical Corporation's Scope 3 emissions, which decreased by 0% last year and increased by approximately 16% since 2018, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 61% of Scope 3 emissions.
Top Scope 3 Categories
Terumo Medical Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Terumo Medical Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
